These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1985000)

  • 1. Enhancement of antibiotic concentrations in gastric mucosa by H2-receptor antagonist. Implications for treatment of Helicobacter pylori infections.
    Westblom TU; Duriex DE
    Dig Dis Sci; 1991 Jan; 36(1):25-8. PubMed ID: 1985000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guinea pig model for antibiotic transport across gastric mucosa: inhibitory tissue concentrations of clindamycin against Helicobacter pylori (Campylobacter pylori) following two separate dose regimens.
    Westblom TU; Duriex DE; Madan E; Belshe RB
    Antimicrob Agents Chemother; 1990 Jan; 34(1):25-8. PubMed ID: 2327758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of cefuroxime and ciprofloxacin in gastric mucosa: comparison to in vitro inhibitory concentrations against Helicobacter pylori.
    Westblom TU; Duriex DE
    Microbiologica; 1991 Jan; 14(1):37-43. PubMed ID: 2067414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sofalcone, a gastroprotective drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori: a randomized controlled comparative trial with cimetidine, an H2-receptor antagonist.
    Higuchi K; Watanabe T; Tanigawa T; Tominaga K; Fujiwara Y; Arakawa T
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S155-60. PubMed ID: 20586860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Helicobacter pylori and human gastric epithelial cells in culture: effect of antiulcer drugs.
    Wagner S; Beil W; Mai UE; Bokemeyer C; Meyer HJ; Manns MP
    Pharmacology; 1994 Oct; 49(4):226-37. PubMed ID: 7831386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histamine-2 receptor expression in gastric mucosa before and after Helicobacter pylori cure.
    Osawa H; Kita H; Ohnishi H; Mutoh H; Ishino Y; Satoh K; Sugano K
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():92-8. PubMed ID: 15943854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric mucosal distribution and clinical efficacy of azithromycin in patients with Helicobacter pylori related gastritis.
    Blandizzi C; Malizia T; Gherardi G; Costa F; Marchi S; Marveggio C; Natale G; Senesi S; Bellini M; Maltinti G; Campa M; Tacca MD
    J Antimicrob Chemother; 1998 Jul; 42(1):75-82. PubMed ID: 9700531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teprenone, but not H2-receptor blocker or sucralfate, suppresses corpus Helicobacter pylori colonization and gastritis in humans: teprenone inhibition of H. pylori-induced interleukin-8 in MKN28 gastric epithelial cell lines.
    Miyake K; Tsukui T; Shinji Y; Shinoki K; Hiratsuka T; Nishigaki H; Futagami S; Wada K; Gudis K; Iwakiri K; Yamada N; Sakamoto C
    Helicobacter; 2004 Apr; 9(2):130-7. PubMed ID: 15068414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastric diffusion of antibiotics used against Helicobacter pylori.
    Lozniewski A; de Korwin JD; Muhale F; Jehl F
    Int J Antimicrob Agents; 1997 Jan; 9(3):181-93. PubMed ID: 9552715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cimetidine with new H2-antagonists in rabbit and guinea pig gastric cells.
    Batzri S; Harmon JW; Toles R
    Eur J Pharmacol; 1983 Oct; 94(1-2):1-8. PubMed ID: 6140169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omeprazole on gastric mucosa and serum levels of amoxicillin in patients with non-ulcer dyspepsia.
    Wittayalertpanya S; Wannachai N; Thongnopnua P; Mahachai V
    J Med Assoc Thai; 2000 Jun; 83(6):611-8. PubMed ID: 10932486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the histamine-stimulated adenylate cyclase activity of guinea pig gastric cells by the H2-receptor antagonists cimetidine, oxmetidine and SKF 93479.
    Cheret AM; Scarpignato C; Lewin MJ; Bertaccini G
    Pharmacology; 1984; 28(5):268-74. PubMed ID: 6728900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Helicobacter pylori infection and serum pepsinogen I concentration in peptic ulcer patients: effect of bacterial eradication.
    Park SM; Park J; Chang SK; Yoo BC; Kim HJ
    Korean J Intern Med; 1996 Jan; 11(1):1-8. PubMed ID: 8882471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levels of malondialdehyde-deoxyguanosine in the gastric mucosa: relationship with lipid peroxidation, ascorbic acid, and Helicobacter pylori.
    Everett SM; Singh R; Leuratti C; White KL; Neville P; Greenwood D; Marnett LJ; Schorah CJ; Forman D; Shuker D; Axon AT
    Cancer Epidemiol Biomarkers Prev; 2001 Apr; 10(4):369-76. PubMed ID: 11319178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic therapy for Helicobacter pylori.
    Collins J; Ali-Ibrahim A; Smoot DT
    Med Clin North Am; 2006 Nov; 90(6):1125-40. PubMed ID: 17116440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probiotics and triple eradication therapy on the cyclooxygenase (COX)-2 expression, apoptosis, and functional gastric mucosal impairment in Helicobacter pylori-infected Mongolian gerbils.
    Brzozowski T; Konturek PC; Mierzwa M; Drozdowicz D; Bielanski W; Kwiecien S; Konturek SJ; Stachura J; Pawlik WW; Hahn EG
    Helicobacter; 2006 Feb; 11(1):10-20. PubMed ID: 16423085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
    Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
    Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and development of cimetidine as a histamine H2-receptor antagonist.
    Brimblecombe RW; Duncan WA; Durant GJ; Emmett JC; Ganellin CR; Leslie GB; Parsons ME
    Gastroenterology; 1978 Feb; 74(2 Pt 2):339-47. PubMed ID: 23336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eradication of Helicobacter pylori reduced the immunohistochemical detection of p53 and MDM2 in gastric mucosa.
    Kodama M; Fujioka T; Murakami K; Okimoto T; Sato R; Watanabe K; Nasu M
    J Gastroenterol Hepatol; 2005 Jun; 20(6):941-6. PubMed ID: 15946145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactive oxygen species activity and lipid peroxidation in Helicobacter pylori associated gastritis: relation to gastric mucosal ascorbic acid concentrations and effect of H pylori eradication.
    Drake IM; Mapstone NP; Schorah CJ; White KL; Chalmers DM; Dixon MF; Axon AT
    Gut; 1998 Jun; 42(6):768-71. PubMed ID: 9691912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.